GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Ekso Bionics Holdings Inc (FRA:23E2) » Definitions » Gross Margin %

Ekso Bionics Holdings (FRA:23E2) Gross Margin % : 53.49% (As of Sep. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Ekso Bionics Holdings Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Ekso Bionics Holdings's Gross Profit for the three months ended in Sep. 2024 was €1.99 Mil. Ekso Bionics Holdings's Revenue for the three months ended in Sep. 2024 was €3.72 Mil. Therefore, Ekso Bionics Holdings's Gross Margin % for the quarter that ended in Sep. 2024 was 53.49%.


The historical rank and industry rank for Ekso Bionics Holdings's Gross Margin % or its related term are showing as below:

FRA:23E2' s Gross Margin % Range Over the Past 10 Years
Min: 13.61   Med: 43.08   Max: 60.01
Current: 51.84


During the past 12 years, the highest Gross Margin % of Ekso Bionics Holdings was 60.01%. The lowest was 13.61%. And the median was 43.08%.

FRA:23E2's Gross Margin % is ranked worse than
50.31% of 805 companies
in the Medical Devices & Instruments industry
Industry Median: 51.89 vs FRA:23E2: 51.84

Ekso Bionics Holdings had a gross margin of 53.49% for the quarter that ended in Sep. 2024 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Ekso Bionics Holdings was 4.00% per year.


Ekso Bionics Holdings Gross Margin % Historical Data

The historical data trend for Ekso Bionics Holdings's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ekso Bionics Holdings Gross Margin % Chart

Ekso Bionics Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 48.61 57.09 60.01 48.13 49.67

Ekso Bionics Holdings Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 53.30 48.86 51.94 53.27 53.49

Competitive Comparison of Ekso Bionics Holdings's Gross Margin %

For the Medical Instruments & Supplies subindustry, Ekso Bionics Holdings's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ekso Bionics Holdings's Gross Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ekso Bionics Holdings's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Ekso Bionics Holdings's Gross Margin % falls into.



Ekso Bionics Holdings Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Ekso Bionics Holdings's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )=Gross Profit (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=8.3 / 16.762
=(Revenue - Cost of Goods Sold) / Revenue
=(16.762 - 8.437) / 16.762
=49.67 %

Ekso Bionics Holdings's Gross Margin for the quarter that ended in Sep. 2024 is calculated as


Gross Margin % (Q: Sep. 2024 )=Gross Profit (Q: Sep. 2024 ) / Revenue (Q: Sep. 2024 )
=2 / 3.72
=(Revenue - Cost of Goods Sold) / Revenue
=(3.72 - 1.73) / 3.72
=53.49 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Ekso Bionics Holdings  (FRA:23E2) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Ekso Bionics Holdings had a gross margin of 53.49% for the quarter that ended in Sep. 2024 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Ekso Bionics Holdings Gross Margin % Related Terms

Thank you for viewing the detailed overview of Ekso Bionics Holdings's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Ekso Bionics Holdings Business Description

Traded in Other Exchanges
Address
101 Glacier Point, Suite A, San Rafael, CA, USA, 94901
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are EksoHealth and EksoWorks. All of the company's operations are held in the United States. The EksoHealth segment which derives majority revenue designs, engineers, manufactures and sells exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The regions company operates in are the Americas, EMEA, and APAC.

Ekso Bionics Holdings Headlines

No Headlines